Clinical Outcomes Data on SkinTE™ from Lower Extremity Chronic

     Wounds to be Presented at Diabetic Limb Salvage (DLS) Conference


SALT LAKE CITY, March 27, 2019 /PRNewswire/ — PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, announced today that two clinical outcomes abstracts on SkinTE™ for the treatment of diabetic foot ulcers (DFUs) will be presented at the Diabetic Limb Salvage (DLS) Conference in Washington, DC being held on April 4-6, 2019. SkinTE is a first-of-its-kind autologous, homologous human cellular and tissue-based product designed to regenerate full-thickness, functional skin for the repair, reconstruction and replacement of patient’s own skin … One of the abstracts, which includes data from the pilot study for a randomized controlled trial evaluating SkinTE for DFUs, has been recognized with a Top Abstract Special Designation. The abstracts are being presented by investigators, independent providers and users of the Company’s SkinTE product …Charles M. Zelen, DPM, Foot and Ankle Associates of Southwest Virginia and Director of Professional Education and Research Institute, will present an abstract on the use of SkinTE for treatment of DFUs. This abstract was selected as one of only three abstracts for a Top Abstract Special Designation. The abstract presentation will detail the status of healing of eleven patients treated with SkinTE as part of the pilot study … read more